We are live on ! Find out more
ANVS icon

Annovis Bio

7 hedge funds and large institutions have $582K invested in Annovis Bio in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2.82% more ownership

Funds ownership: 0%2.82% (+2.8%)

Holders
7
Holders Change
+7
Holders Change %
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WVP
1
Worth Venture Partners
New Jersey
$432K +$708K +143,750 New
ZCA
2
Zeke Capital Advisors
Pennsylvania
$83K +$136K +27,594 New
CC
3
Cannell & Co
New York
$30K +$49.2K +10,000 New
KJHP
4
K.J. Harrison & Partners
Ontario, Canada
$30K +$49.2K +10,000 New
Bank of America
5
Bank of America
North Carolina
$4K +$6.03K +1,225 New
Victory Capital Management
6
Victory Capital Management
Texas
$2K +$1.89K +384 New
Osaic Holdings
7
Osaic Holdings
Arizona
$1K +$2.09K +425 New

ANVS Hedge Fund Activity: Q1 2020 in Review

7 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q1 2020, worth a combined $582K.

Buyers outnumbered sellers: 7 funds opened new ANVS positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Worth Venture Partners, opening a new position worth an estimated $708K.

  • 7 institutional investors held Annovis Bio (ANVS) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $582K of Annovis Bio stock for Q1 2020.
  • 7 funds opened new Annovis Bio positions in Q1 2020 and 0 closed out, a net change of +7 holders.
  • The largest Annovis Bio buyer in Q1 2020 was Worth Venture Partners, an estimated $708K added.

Based on aggregated 13F filings for Q1 2020.